• Je něco špatně v tomto záznamu ?

Disruption of dopamine D1/D2 receptor complex is involved in the function of haloperidol in cardiac H9c2 cells

L. Lencesova, I. Szadvari, P. Babula, J. Kubickova, B. Chovancova, K. Lopusna, I. Rezuchova, Z. Novakova, O. Krizanova, M. Novakova,

. 2017 ; 191 (-) : 186-194. [pub] 20171018

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18016269

AIMS: Haloperidol is an antipsychotic agent and acts as dopamine D2 receptor (D2R) antagonist, as a prototypical ligand of sigma1 receptors (Sig1R) and it increases expression of type 1 IP3 receptors (IP3R1). However, precise mechanism of haloperidol action on cardiomyocytes through dopaminergic signaling was not described yet. This study investigated a role of dopamine receptors in haloperidol-induced increase in IP3R1 and Sig1R, and compared physiological effect of melperone and haloperidol on basic heart parameters in rats. MATERIALS AND METHODS: We used differentiated NG-108 cells and H9c2 cells. Gene expression, Western blot and immunofluorescence were used to evaluate haloperidol-induced differences; proximity ligation assay (PLA) and immunoprecipitation to determine interactions of D1/D2 receptors. To evaluate cardiac parameters, Wistar albino male rats were used. KEY FINDINGS: We have shown that antagonism of D2R with either haloperidol or melperone results in upregulation of both, IP3R1 and Sig1R, which is associated with increased D2R, but reduced D1R expression. Immunofluorescence, immunoprecipitation and PLA support formation of heteromeric D1/D2 complexes in H9c2 cells. Treatment with haloperidol (but not melperone) caused decrease in systolic and diastolic blood pressure and significant increase in heart rate. SIGNIFICANCE: Because D1R/D2R complexes can engage Gq-like signaling in other experimental systems, these results are consistent with the possibility that disruption of D1R/D2R complex in H9c2 cells might cause a decrease in IP3R1 activity, which in turn may account for the increase expression of IP3R and Sig1R. D2R is probably not responsible for changes in cardiac parameters, since melperone did not have any effect.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016269
003      
CZ-PrNML
005      
20180523095245.0
007      
ta
008      
180515s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.lfs.2017.10.026 $2 doi
035    __
$a (PubMed)29054453
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Lencesova, L $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
245    10
$a Disruption of dopamine D1/D2 receptor complex is involved in the function of haloperidol in cardiac H9c2 cells / $c L. Lencesova, I. Szadvari, P. Babula, J. Kubickova, B. Chovancova, K. Lopusna, I. Rezuchova, Z. Novakova, O. Krizanova, M. Novakova,
520    9_
$a AIMS: Haloperidol is an antipsychotic agent and acts as dopamine D2 receptor (D2R) antagonist, as a prototypical ligand of sigma1 receptors (Sig1R) and it increases expression of type 1 IP3 receptors (IP3R1). However, precise mechanism of haloperidol action on cardiomyocytes through dopaminergic signaling was not described yet. This study investigated a role of dopamine receptors in haloperidol-induced increase in IP3R1 and Sig1R, and compared physiological effect of melperone and haloperidol on basic heart parameters in rats. MATERIALS AND METHODS: We used differentiated NG-108 cells and H9c2 cells. Gene expression, Western blot and immunofluorescence were used to evaluate haloperidol-induced differences; proximity ligation assay (PLA) and immunoprecipitation to determine interactions of D1/D2 receptors. To evaluate cardiac parameters, Wistar albino male rats were used. KEY FINDINGS: We have shown that antagonism of D2R with either haloperidol or melperone results in upregulation of both, IP3R1 and Sig1R, which is associated with increased D2R, but reduced D1R expression. Immunofluorescence, immunoprecipitation and PLA support formation of heteromeric D1/D2 complexes in H9c2 cells. Treatment with haloperidol (but not melperone) caused decrease in systolic and diastolic blood pressure and significant increase in heart rate. SIGNIFICANCE: Because D1R/D2R complexes can engage Gq-like signaling in other experimental systems, these results are consistent with the possibility that disruption of D1R/D2R complex in H9c2 cells might cause a decrease in IP3R1 activity, which in turn may account for the increase expression of IP3R and Sig1R. D2R is probably not responsible for changes in cardiac parameters, since melperone did not have any effect.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné linie $7 D002460
650    _2
$a antagonisté dopaminu $x farmakologie $7 D018492
650    _2
$a antagonisté dopaminu D2 $x farmakologie $7 D065127
650    _2
$a regulace genové exprese $x účinky léků $7 D005786
650    _2
$a haloperidol $x farmakologie $7 D006220
650    _2
$a srdce $x účinky léků $7 D006321
650    _2
$a srdeční frekvence $x účinky léků $7 D006339
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a vazba proteinů $x účinky léků $7 D011485
650    _2
$a potkani Wistar $7 D017208
650    _2
$a receptory dopaminu D1 $x genetika $x metabolismus $7 D017447
650    _2
$a receptory dopaminu D2 $x genetika $x metabolismus $7 D017448
650    _2
$a signální transdukce $x účinky léků $7 D015398
655    _2
$a časopisecké články $7 D016428
700    1_
$a Szadvari, I $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Babula, P $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Kubickova, J $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Chovancova, B $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Lopusna, K $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Rezuchova, I $u Institute of Virology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
700    1_
$a Novakova, Z $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Krizanova, O $u Institute of Clinical and Translational Research, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia; Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Electronic address: olga.krizanova@savba.sk.
700    1_
$a Novakova, M $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Electronic address: majka@med.muni.cz.
773    0_
$w MED00003147 $t Life sciences $x 1879-0631 $g Roč. 191, č. - (2017), s. 186-194
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29054453 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180523095429 $b ABA008
999    __
$a ok $b bmc $g 1299893 $s 1013109
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 191 $c - $d 186-194 $e 20171018 $i 1879-0631 $m Life sciences $n Life Sci $x MED00003147
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace